Page 51 - ITPS-6-1

45 INNOSC Theranostics and Pharmacological Sciences, 2023, Vol. 6, No. 1 Hariharan
2007, 29, 334–7. with Sickle Cell Disease. J. Pediatr. Hematol. Oncol., 2009, 31,
[39] Nouraie, M.; Darbari, D.S.; Rana, S.; Minniti, C.P.; Castro, O.L.; 97-100.
Luchtman-Jones, L.; Sable, C.; Dham, N.; Kato, G.J.; [47] Sokunbi, O.J.; Ekure, E.N.; Temiye, E.O.; Anyanwu, R.;
Gladwin, M.T.; Ensing, G.; Arteta, M.; Campbell, A.; Taylor, J.G Okoromah, C.A.N. Pulmonary Hypertension among 5 to 18 Year
6 .; Nekhai, S.; Gordeuk, V.R. Tricuspid Regurgitation Velocity Old Children with Sickle Cell Anaemia in Nigeria. PLoS One.
th
and Other Biomarkers of Mortality in Children, Adolescents and 2017, 12, e0184287.
Young Adults with Sickle Cell Disease in the United States: The [48] Suell, M.N.; Bezold, L.I.; Okcu, M.F.; Mahoney, D.H. Jr.;
PUSH Study. Am. J. Hematol., 2020, 95, 766–74. Bertuch, A.A. Increased Pulmonary Artery Pressures among
[40] Onalo, R.; Cooper, P.; Cilliers, A.; Nnebe-Agumadu, U. Adolescents with Sickle Cell Disease. J. Pediatr. Hematol. Oncol.,
Cardiovascular Changes in Children with Sickle Cell Crisis. 2005, 27, 654–8.
Cardiol. Young, 2020, 30, 162–70. [49] Musa, B.M.; Galadanci, N.A.; Coker, M.; Bussell, S.; Aliyu, M.H.
[41] Onyekwere, O.C.; Campbell, A.; Teshome, M.; Onyeagoro, S.; The Global Burden of Pulmonary Hypertension in Sickle Cell
Sylvan, C.; Akintilo, A.; Hutchinson, S.; Ensing, G.; Gaskin, P.; Disease: A Systematic Review and Meta-Analysis. Ann. Hematol.,
Kato, G.; Rana, S.; Kwagyan, J.; Gordeuk, V.; Williams, J.; 2016, 95, 1757–64.
Castro, O. Pulmonary Hypertension in Children and Adolescents [50] Bigna, J.J.; Noubiap, J.J.; Nansseu, J.R.; Aminde, L.N. Prevalence
with Sickle Cell Disease. Pediatr. Cardiol., 2008, 29, 309–12. and Etiologies of Pulmonary Hypertension in Africa: A Systematic
[42] Pashankar, F.D.; Carbonella, J.; Bazzy-Asaad, A.; Friedman, A.
Prevalence and Risk Factors of Elevated Pulmonary Artery Review and Meta-Analysis. BMC Pulm. Med., 2017, 17, 183.
Pressures in Children with Sickle Cell Disease. Int. J. Contemp. [51] Bigna, J.J, Nansseu, J.R.; Noubiap, J.J. Pulmonary Hypertension in
Pediatr., 2008, 121, 777–82. the Global Population of Adolescents and Adults Living with HIV:
[43] Patel, P.; Sharma, S.; Shah, N.; Manglani, M. Prevalence of A Systematic Review and Meta-Analysis. Sci. Rep., 2019, 9, 7837.
Pulmonary Hypertension in Children with Sickle Cell Disease. [52] Schoenberg, N.C.; Argula, R.G.; Klings, ES.; Wilson, K.C.;
Int. J. Contemp. Pediatr., 2016, 3, 1076–82. Farber, H.W. Prevalence and Mortality of Pulmonary Hypertension
[44] Peter, I.D.; Asani, M.O., Abdullahi, S.U.; Aliyu, I.; Obaro, S.K.; in ESRD: A Systematic Review and Meta-Analysis. Lung. 2020,
Bode-Thomas, F. Pulmonary Hypertension and Right Ventricular 198, 535–45.
Function in Nigerian Children with Sickle Cell Anaemia. Trans. R. [53] Avouac, J.; Airò, P.; Meune, C.; Beretta, L.; Dieude, P.;
Soc. Trop. Med. Hyg., 2019, 113, 489–96. Caramaschi, P.; Tiev, K.; Cappelli, S.; Diot, E.; Vacca, A.;
[45] Qureshi, N.; Joyce, J.J.; Qi, N.; Chang, R.K. Right Ventricular Cracowski, J.L.; Sibilia, J.; Kahan, A.; Matucci-Cerinic, M.;
Abnormalities in Sickle Cell Anemia: Evidence of a Progressive Allanore, Y. Prevalence of Pulmonary Hypertension in Systemic
Increase in Pulmonary Vascular Resistance. J. Pediatr., 2006, 149, Sclerosis in European Caucasians and Meta-Analysis of 5 Studies.
23–7. J. Rheumatol., 2010, 37, 2290–8.
[46] Sedrak, A.; Rao, S.P.; Miller, S.T.; Hekmat, V.; Rao, M. [54] Rhodes, C.J.; Wharton, J.; Wilkins, M.R. Pulmonary Hypertension:
A Prospective Appraisal of Pulmonary Hypertension in Children Biomarkers. Handb. Exp. Pharmacol., 2013, 218, 77–103.

Publisher's note
AccScience Publishing remains neutral with regard
to jurisdictional claims in published maps and
institutional affiliations.

©2023 AccScience Publishing